Autolus Therapeutics plc (AUTL)
Data as of , from SEC Form 4 filings.
See up to 3 months of AUTL. The 7-day demo opens the 1M and 3M ranges and puts AUTL on your watchlist.
Start 7-day demoLatest AUTL insider trades
About Autolus Therapeutics plc (AUTL)
The SEC lists Autolus Therapeutics plc under CIK 0001730463, in biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
AUTL Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 6,713 | $16K |
| Option exercise | 2 | 40,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
AUTL insider transactions (Form 4)
2110 Form 4 filings on record, the earliest from Jul 1, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Cintia Piccina - Officer | Option exercise | American Depositary Shares | 20,000 | $2.35 | $47K | |
| Cintia Piccina - Officer | Open-market sale | American Depositary Shares | 6,713 | $2.34 | $16K | |
| Cintia Piccina - Officer | Option exercise | Restricted Share Units | 20,000 | $0.00 | - | |
| William D. Young - Director | Grant or award | Restricted Share Units | 31,667 | $0.00 | - | |
| William D. Young - Director | Grant or award | Share Option (Right to Buy) | 47,500 | $0.00 | - | |
 Madduri Ravin Rao - Director | Grant or award | Restricted Share Units | 31,667 | $0.00 | - | |
| Madduri Ravin Rao - Director | Grant or award | Share Option (Right to Buy) | 47,500 | $0.00 | - | |
| Ryan Richardson - Director | Grant or award | Restricted Share Units | 31,667 | $0.00 | - | |
| Ryan Richardson - Director | Grant or award | Share Option (Right to Buy) | 47,500 | $0.00 | - | |
| Elisabeth Leiderman - Director | Grant or award | Restricted Share Units | 31,667 | $0.00 | - | |
| Elisabeth Leiderman - Director | Grant or award | Share Option (Right to Buy) | 47,500 | $0.00 | - | |
| Robert Iannone - Director | Grant or award | Restricted Share Units | 31,667 | $0.00 | - | |
| Robert Iannone - Director | Grant or award | Share Option (Right to Buy) | 47,500 | $0.00 | - | |
| Cynthia M. Butitta - Director | Grant or award | Restricted Share Units | 31,667 | $0.00 | - | |
| Cynthia M. Butitta - Director | Grant or award | Share Option (Right to Buy) | 47,500 | $0.00 | - | |
 Linda Bain - Director | Grant or award | Restricted Share Units | 31,667 | $0.00 | - | |
| Linda Bain - Director | Grant or award | Share Option (Right to Buy) | 47,500 | $0.00 | - | |
| Robert Azelby - Director | Grant or award | Share Option (Right to Buy) | 47,500 | $0.00 | - | |
| Robert Azelby - Director | Grant or award | Restricted Share Units | 31,667 | $0.00 | - | |
| Michael W. Bonney - Director | Grant or award | Restricted Share Units | 31,667 | $0.00 | - | |
| Michael W. Bonney - Director | Grant or award | Share Option (Right to Buy) | 47,500 | $0.00 | - |
Recent AUTL Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Piccina Cintia | Officer | 6,713 | $16K | View on EDGAR |
AUTL insider trading FAQ
What is the latest insider trade for AUTL?
Autolus Therapeutics plc (AUTL) had 1 insider filing in the last 90 days, with the most recent on 2026-09-03. The full record for AUTL runs to 10 Form 4 filings, the earliest from 2026-07-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AUTL stock?
No insider purchases of AUTL were filed in the last 90 days.
How many insiders are selling AUTL stock?
1 insider sale of AUTL was filed in the last 90 days, totaling $16K.
Where can I see AUTL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AUTL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Cintia Piccina view on EDGAR
- - William D. Young view on EDGAR
- - Madduri Ravin Rao view on EDGAR
- - Ryan Richardson view on EDGAR
- - Elisabeth Leiderman view on EDGAR
- - Robert Iannone view on EDGAR
- - Cynthia M. Butitta view on EDGAR
- - Linda Bain view on EDGAR
- - Robert Azelby view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where AUTL's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AUTL with a 7-day demo
- AUTL on your watchlist
- Every AUTL Form 4 filing on record
- Up to 3 months of AUTL price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
